Applied Materials, Inc. (AMAT) is currently at $366.35, up $37.96 or 11.56% --Would be new all-time closing high (Based on available data back to Oct. 23, 1972) --On pace for largest percent increase ...
Applied Materials has reached an agreement with the U.S. Department of Commerce over alleged violations of controls on ...
We recently published 10 Stocks Delivering Outsized Gains; 3 Are Hitting Record Highs. Applied Digital Corp. (NASDAQ:APLD) was one of the best performers on Friday. Applied Digital snapped a three-day ...
Shares of digital infrastructure provider Applied Digital (NASDAQ:APLD) jumped 4.8% in the afternoon session after investor optimism grew on the back of its strong growth pipeline, a substantial order ...
Jan 7 (Reuters) - Applied Digital (APLD.O), opens new tab reported second-quarter revenue above Wall Street estimates on Wednesday, as the data center operator benefited from strong demand for its ...
Applied Digital is in the right place at the right time as AI spending ramps up. Its ability to achieve projects on time and on budget may help it win over the trust of big tech companies. A single ...
CHONGQING, CHINA - SEPTEMBER 28: In this photo illustration, a hand holds a smartphone displaying the logo of Applied Digital Corporation (NASDAQ: APLD), the American company specializing in data ...
Applied Digital (APLD) posted $64.2M in Q1 revenue with 84% growth while CoreWeave (CRWV) reported $1.36B in Q3 revenue with 134% growth. CoreWeave generated $51.9M in operating income and doubled its ...
At first blush, Chinese e-commerce enterprise JD.com, Inc. (NASDAQ: JD) seems to have cast a dark shadow over bullish investors. For one thing, the performance of JD stock hasn't been all that great, ...
Facing skepticism from analysts about whether it has the resources to take its rare disease drug to market, Applied Therapeutics is laying off almost half of the biotech's workforce to conserve its ...
Applied Therapeutics’ lack of progress on govorestat as well as the potential costs to come have led analysts to question whether the biotech will ever be able to get the drug to market. The New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results